The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation.

ABSTRACT:

SUBMITTER: Khorana AA 

PROVIDER: S-EPMC6590399 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature